USPTO serial 79405666
HYDIFFUZE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 2, 2025
- Examiner
- RUIZ SANTIAGO, REBECCA E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HYDIFFUZE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R Menker
James R Menker Holley & Menker, PA60 Ocean Boulevard, Suite 3Atlantic Beach, FL 32233United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; enzymes for veterinary purposes; ferments for pharmaceutical purposes; pharmaceutical agents for epidermis; cellular function activating agents for medical purposes; medicinal creams for skin care; enzymes for medical purposes; enzyme preparations for medical purposes; medicines for human purposes, namely, injectable medication containing hyaluronidase for the treatment of cancer, auto-immune diseases, neurological disorders and chronic pain; enzyme preparations for medical purposes containing recombinant human hyaluronidase as an active ingredient; enzymes for medical purposes containing recombinant human hyaluronidase; medicated skin care preparations | ACTIVE | — |
| 042 | Research and development of siRNA drugs; scientific research; research and development of vaccines and medicines; biomedical research services; drug discovery services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research services; research on the subject of pharmaceuticals; development of gene-based medicines; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; consultancy in the field of testing, inspection, research of medical products; medical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HuonsLab Co., Ltd.
- Other trademarks owned by HuonsLab Co., Ltd.
- Other trademarks owned by HuonsLab Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named HYDIFFUZE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 1, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 1, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 19, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 2, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 2, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 2, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 14, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 14, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 16, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 15, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2025 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Mar 7, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 16, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |